Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone, new findings by UT Southwestern Medical Center researchers suggest.
Joslin Diabetes Center researchers have identified a key molecular player that contributes to the increased bleeding that hemorrhagic strokes may cause in people with diabetes.
Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.
According to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM), exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
A recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM), found higher Bisphenol A (BPA) levels in women with polycystic ovary syndrome (PCOS) compared to controls. Furthermore, researchers found a statistically significant positive association between male sex hormones and BPA in these women suggesting a potential role of BPA in ovarian dysfunction.
Approximately 19 million U.S. adults reported receiving treatment for diabetes in 2007, more than double the 9 million who said they received care in 1996.
Depression and diabetes appear to be associated with a significantly increased risk of death from heart disease and risk of death from all causes over a six-year period for women, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Patients with diabetes, kidney disease and anemia who don’t respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.
New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called “starvation hormone” affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival.
City Tech Nursing Prof. Kathleen Falk's research indicates that a community-based care plan and regular disease marker monitoring made a difference in health outcomes in patients with obstacles to diabetes management.
In addition to fast food, desk jobs, and inertia, there is one more thing to blame for unwanted pounds-our genome, which has apparently not caught up with the fact that we no longer live in the Stone Age.
A myriad of inputs can indicate a body’s health bombard pancreatic beta cells continuously, and these cells must consider all signals and “decide” when and how much insulin to release to maintain balance in blood sugar, for example. Reporting in Nature Chemical Biology last month, researchers at the Johns Hopkins University School of Medicine have teased out how these cells interpret incoming signals and find that three proteins relay signals similar to an electrical circuit.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab® Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association (ADA) to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance (IGT) in older adults. IGT occurs when blood glucose levels are higher than normal, but not high enough to be considered diabetes. The condition is also known as prediabetes.
For patients living with diabetes, reducing the amount of salt in their daily diet is key to warding off serious threats to their health, a new review of studies finds.
A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
Temple University students create a YouTube channel called Diabetes Diaries, where people with diabetes, or friends and family members of diabetics, can upload videos to tell their stories.
Sally Pinkstaff, M.D., Ph.D., F.A.C.E., F.A.C.P., an endocrinologist at Sinai Hospital of Baltimore, is available as an expert on diabetes- how it can be prevented and how it is treated.
Two studies from the Childhood Obesity Research Center at the Keck School of Medicine of the University of Southern California (USC) have found evidence that Hispanic children and adolescents are genetically predisposed to developing fatty liver disease—a condition that can lead to cirrhosis, cardiovascular disease and diabetes.
Diabetes expert Dr. Deneen Vojta, MD, co-creator of Unitedhealth Group’s Diabetes Prevention and Control Alliance, is available for interviews throughout National Diabetes Awareness Month.
New findings by researchers at UT Southwestern Medical Center suggest that serotonin – a brain chemical known to help regulate emotion, mood and sleep – might also have anti-diabetic properties.
Physicians, nurses and other health care providers can have some of the most up-to-date information on the growing diabetes epidemic at their fingertips, thanks to the release of a new Johns Hopkins guide to the disease now available on all smart phone devices.
A new study of nearly 70,000 women found a clear association between abuse in childhood and adolescence and the risk of type 2 diabetes in adult women.
A donation from the Thomas J. Beatson, Jr. Foundation will broaden access to Joslin's care ambassadors program for youth newly diagnosed with diabetes.
A fatal genetic disorder that frequently takes years to diagnose may soon be detectable with a simple blood test. For patients with Niemann-Pick type C disease, the test will make it possible to begin treatment earlier, when it is more likely to improve quality of life and to further extend lives.
Researchers at the University of California, San Diego School of Medicine have discovered that a multi-tasking protein called FoxO1 has another important but previously unknown function: It directly interacts with macrophages, promoting an inflammatory response that can lead to insulin resistance and diabetes.
A University at Buffalo endocrinologist has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.
New findings by UT Southwestern Medical Center researchers suggest a novel role for the brain in mediating beneficial actions of the hormone leptin in type 1 diabetes.
Phone calls with a peer facing the same self-management challenges helped diabetes patients manage their conditions and improved their blood sugar levels better than those who used traditional nurse care management alone.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer’s disease.
University of Michigan scientists have identified events inside pancreatic cells that set the stage for a neonatal form of non-autoimmune Type 1 diabetes, and may play a role in Type 2 diabetes.
A rapid increase in the number of hospitalizations due to diabetes for young adults – particularly young women – echoes the dramatic increase in rates of obesity across the United States in the last 30 years, according to a U-M study published in Journal of Women’s Health.
A clinical trial at UT Southwestern Medical Center aims to determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes.
Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.
A research team led by Mount Sinai School of Medicine has identified the mechanism behind a single gene linked to the causes of both Alzheimer’s disease and Type 2 diabetes. The data show that a gene for a protein called SorCS1, which can cause Type 2 diabetes, impacts the accumulation of amyloid-beta (Abeta) in the brain. Abeta plays a key role in the development of Alzheimer’s disease.
International experts in type 2 diabetes will gather in Rome on September 27-28 to discuss how metabolic surgery may open new treatment opportunities for the disorder, which is on the rise worldwide.
An intensive lifestyle intervention appears to help individuals with type 2 diabetes lose weight and keep it off, along with improving fitness, control of blood glucose levels and risk factors for cardiovascular disease, according to a report in the September 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers. In a study comparing diabetic mice treated with chromium picolinate with those that received placebo, the researchers found that mice who received the supplement had lower levels of albuminuria (protein in the urine), an indication of kidney disease.
Researchers from Albert Einstein College of Medicine of Yeshiva University will hold a congressional briefing in Washington, D.C., aimed at focusing attention on the alarming global diabetes epidemic. Incidence of diabetes is increasing worldwide at a rate that eclipses most other diseases. The World Health Organization estimates that by the year 2030, more than 366 million people will be suffering from diabetes, 10 times the number affected by HIV/AIDS. Of that 366 million, more than 298 million will live in developing countries.
South Asians living in the United States are at much higher risk for type 2 diabetes than are whites and immigrants from other Asian countries, a new small study reveals.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale biomarkers being sought in research funded by the U.S. Department of Agriculture (USDA) and the National Institutes of Health.